Stanford University
Showing 21-30 of 739 Results
-
Pooja Kakar
Member, Maternal & Child Health Research Institute (MCHRI)
Current Research and Scholarly InterestsAs a breastfeeding medicine physician, I am passionate about advocating for mother-infant dyads and supporting their breastfeeding journeys. Additionally, I am interested studying and addressing disparities in initiation and duration of breastfeeding, particularly in lower-resourced populations, by building and advancing community partnerships.
I am also interested in the use of digital health tools to advance upstream determinants of health in community-based settings. My current funded research projects include: 1) Providing a telehealth-based, weight control program to children with obesity from lower-income, racial and ethnic minority families (Gardner GOALS) and 2) Assessing and addressing disparities in healthy behaviors in families from under-resourced settings through the use of a secure, multilingual mobile neighborhood app (Our Voice: Beyond Clinic Walls). -
Sharada Kalanidhi
Director of Data Science, Biochemistry - Genome Center
Current Role at StanfordParaphrasing the mathematician Alexander Grothendieck: the essential thing is to pose problems in the right framework.
Sharada is developing a new field, Mathematical Medicine, which applies pure mathematical frameworks to genomic and multi-omic data for quantitative, personalized diagnosis. Her work addresses a fundamental challenge in contemporary medicine: prevailing cohort-based diagnostic approaches are not always equipped to capture the biological mechanisms relevant to individual patients, particularly in long-pending, complex “outlier” cases.
After more than a decade of research and close collaboration with biochemists at the Stanford Genome Technology Center (Dept. of Biochemistry), Sharada concluded that the mathematics currently used for multi-omic diagnosis is not sufficient for the level of biological and clinical complexity being attempted, particularly for individual patients who lack relevant statistical cohorts. Her conclusion echoes the perspective of the mathematician Mikhail Gromov: “This area does not yet exist. It will have to be invented.” This gap has important clinical consequences: individual biological differences may be treated as “noise” or as "outliers" rather than as clinically meaningful information. As a result, many patients with complex or multi-system conditions remain undiagnosed or incorrectly diagnosed, sometimes for decades, delaying effective treatment and, in some cases, allowing disease processes to worsen.
Mathematical Medicine addresses these limitations by developing an intermediate translational layer between cohort-based statistical models and individualized multi-omic diagnosis and clinical decision-making. The approach reflects the data-first philosophy articulated by the late mathematician Jim Simons: “We don’t start with models. We start with data. We don’t have any preconceived notions.” By developing new mathematical frameworks for interpreting an individual’s genomic and multi-omic data, Mathematical Medicine seeks to seeks to let the data speak for itself while enabling quantitative, individualized diagnosis and clinical decision-making.
Sharada’s research has led to the diagnosis and identification of appropriate treatment pathways for patients with previously undiagnosed, complex conditions. These rare and atypical cases also reveal biological relationships not apparent in population-level analyses, leading to insights that can inform broader research, clinical applications, and drug development.
Further information on this field, including opportunities for early philanthropic partnerships, is available at: https://mathmed-2026.web.app -
Anusha Kalbasi, MD
Associate Professor of Radiation Oncology (Radiation Therapy)
BioDr. Kalbasi is a physician-scientist at the Stanford Cancer Institute. In the clinic, Dr. Kalbasi is a radiation oncologist specializing in the treatment of patients with sarcoma and other solid tumors, with expertise in early phase clinical trials related to immunotherapy, cellular therapy, and radiation therapy.
The Kalbasi laboratory studies cancer immunology, with a focus on understanding—and re-engineering—the molecular conversations that immune cells have with one another and with cancer cells, especially through cytokines. By mapping how these signals are sent, received, and interpreted within immune cells and cancer cells, the lab aims to design next-generation immunotherapies that deliver the right messages at the right time—making cancer-fighting cells more potent, more persistent, and more precise. -
Agnieszka Kalinowski
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioI am a translational physician-scientist committed to understanding the pathophysiology of schizophrenia to identify disease-modifying therapeutic interventions. I examined the role of C4 protein activation in clinical samples from individuals with schizophrenia compared to controls, its relationship to C4 CNV and effect on blood brain barrier permeability using in vitro model systems. I contributed to identifying LINE-1 insertions in postmortem brain samples of individuals with schizophrenia and C4 copy number variation (CNV) in pediatric patients with neuropsychiatric symptoms. Since accumulating evidence points to the synapses as the locus of pathology in schizophrenia, I am focusing my current research effort to defining the underlying abnormality in synapses in schizophrenia using a combination of in vitro iPS based model systems and postmortem brain samples, and applying cutting-edge techniques like spatial transcriptomics and array tomography.
-
Nathan Kalinowski, D.M.D.
Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Nathan Kalinowski is a Hospital Dentist and Clinical Assistant Professor in Dental Medicine and Surgery. He performs medically necessary dental clearance and extractions for patients preparing for cardiac surgery, radiation therapy, or organ transplantation. He also performs surgical treatment of infection and trauma to the teeth and supporting alveolar bone including reconstruction using dental implants.
-
Mausam Kalita
Physical Science Research Professional 2, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordSenior Research Scientist: a) cold chemical synthesis— Synthesis of the 12C and 19F- HPLC standards and precursors for 11C- and 18F- labeling
b) Radiosynthesis— Introduction of 11C or 18F radioisotopes into small molecules to develop novel PET tracers, that can track activated myeloid cells in neurodegenerative disease, c) radiometal labeling— 64Cu and 89Zr labeling of monoclonal antibodies that target immune receptors, d) clinical translation— To follow FDA guidelines for translating preclinically validated tracers into humans in the cyclotron and radiochemistry facility (CRF) of the Stanford University
